Login Register Cart 0
Generic placeholder image

Infectious Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5265
ISSN (Online): 2212-3989

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

A Review on the Antibiotic Resistance of Shigella Strains in Iran

Author(s): Mahdi Shooraj, Marziye Taheri and Mohammadmahdi Karimi-Yazdi*

Volume 24, Issue 1, 2024

Published on: 31 August, 2023

Article ID: e110823219657 Pages: 10

DOI: 10.2174/1871526523666230811093114

Price: $65

conference banner
Abstract

Shigella infection is commonly related to diarrhea and has been a noteworthy source of morbidity and mortality worldwide. There is a wide range of symptoms associated with these contagious microorganisms, from watery diarrhea to fulminant dysentery manifesting with recurrent bloody stools, fever, and prostration. While the mortality rate from Shigellosis has decreased significantly during the past three decades, it remains a principal cause of death in the world. The use of antibiotics in Shigella treatment remarkably lowers the mortality rates and even the prevalence of the infection. However, strains are becoming increasingly resistant, while antibiotics are becoming increasingly ineffective. Shigella species, which were previously susceptible to common antibiotics such as nalidixic acid, co-trimoxazole, chloramphenicol, and ampicillin, have become resistant to cephalosporins, fluoroquinolones and macrolides like azithromycin. These strains have caused many Shigellosis outbreaks. Men who have had sex with men (MSM) and travelers have contributed to the spreading of multiresistant Shigella strains across continents, which has prompted new antibiotic recommendations. People should be informed about the threat of antimicrobial-resistant bacteria, so a periodic report of antibiotic susceptibility after analysis is essential for antibiotic treatment guidance. The present study provides a brief overview of the pathogenicity of Shigella spp., and the antibiotic resistance patterns of two common Shigella species during the last seven years in Iran were evaluated.

Graphical Abstract

[1]
Sansonetti PJ. III. Shigellosis: From symptoms to molecular pathogenesis. Am J Physiol Gastrointest Liver Physiol 2001; 280(3): G319-23.
[http://dx.doi.org/10.1152/ajpgi.2001.280.3.G319] [PMID: 11171613]
[2]
Kotloff KL, Winickoff JP, Ivanoff B, et al. Global burden of Shigella infections: Implications for vaccine development and implementation of control strategies. Bull World Health Organ 1999; 77(8): 651-66.
[PMID: 10516787]
[3]
World Health Organization. Extensively drug-resistant Shigella sonnei infections - Europe - European Region (EURO). 2022. Available from: http://www.who.int/emergencies/disease-outbreak-news/item/2022-DON364#:~:text=Shigellosis%20is%20endemic%20in%20most,diarrhoea%20and%20700%20000%20deaths
[4]
Khalil IA, Troeger C, Blacker BF, et al. Morbidity and mortality due to Shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990–2016. Lancet Infect Dis 2018; 18(11): 1229-40.
[http://dx.doi.org/10.1016/S1473-3099(18)30475-4] [PMID: 30266330]
[5]
Mani S, Wierzba T, Walker RI. Status of vaccine research and development for Shigella. Vaccine 2016; 34(26): 2887-94.
[http://dx.doi.org/10.1016/j.vaccine.2016.02.075] [PMID: 26979135]
[6]
Guarino A, Ashkenazi S, Gendrel D, Lo Vecchio A, Shamir R, Szajewska H. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: Update 2014. J Pediatr Gastroenterol Nutr 2014; 59(1): 132-52.
[http://dx.doi.org/10.1097/MPG.0000000000000375] [PMID: 24739189]
[7]
Mattock E, Blocker AJ. How do the virulence factors of Shigella work together to cause disease? Front Cell Infect Microbiol 2017; 7: 64.
[http://dx.doi.org/10.3389/fcimb.2017.00064] [PMID: 28393050]
[8]
Baker KS, Dallman TJ, Field N, et al. Horizontal antimicrobial resistance transfer drives epidemics of multiple Shigella species. Nat Commun 2018; 9(1): 1462.
[http://dx.doi.org/10.1038/s41467-018-03949-8] [PMID: 29654279]
[9]
Sadaka Y, Freedman J, Ashkenazi S, et al. The effect of antibiotic treatment of early childhood shigellosis on long-term prevalence of attention deficit/hyperactivity disorder. Children 2021; 8(10): 880.
[http://dx.doi.org/10.3390/children8100880] [PMID: 34682145]
[10]
Qu F, Bao C, Chen S, et al. Genotypes and antimicrobial profiles of Shigella sonnei isolates from diarrheal patients circulating in Beijing between 2002 and 2007. Diagn Microbiol Infect Dis 2012; 74(2): 166-70.
[http://dx.doi.org/10.1016/j.diagmicrobio.2012.06.026] [PMID: 22858547]
[11]
Baker KS, Dallman TJ, Ashton PM, et al. Intercontinental dissemination of azithromycin-resistant shigellosis through sexual transmission: A cross-sectional study. Lancet Infect Dis 2015; 15(8): 913-21.
[http://dx.doi.org/10.1016/S1473-3099(15)00002-X] [PMID: 25936611]
[12]
Shigellosis. European Centre for Disease Prevention and Control. 2021.
[13]
Kotloff KL, Nataro JP, Blackwelder WC, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): A prospective, case-control study. Lancet 2013; 382(9888): 209-22.
[http://dx.doi.org/10.1016/S0140-6736(13)60844-2] [PMID: 23680352]
[14]
Moradi F, Hadi N, Akbari M, Hashemizadeh Z, Jahromi RR. Frequency and antimicrobial resistance of Shigella species in Iran during 2000-2020. Jundishapur J Health Sci 2021; 13(2)
[15]
MacLennan CA, Grow S, Ma L, Steele AD. The Shigella vaccines pipeline. Vaccines 2022; 10(9): 1376.
[http://dx.doi.org/10.3390/vaccines10091376] [PMID: 36146457]
[16]
Sack DA, Hoque S, Etheridge M, Huq A. Is protection against shigellosis induced by natural infection with Plesiomonas shigelloides? Lancet 1994; 343(8910): 1413-5.
[http://dx.doi.org/10.1016/S0140-6736(94)92531-3] [PMID: 7910890]
[17]
Saeed A, Johansson D. Sandström G, Abd H. Temperature depended role of Shigella flexneri invasion plasmid on the interaction with Acanthamoeba castellanii. Int J Microbiol 2012; 2012: 917031.
[18]
Anderson M, Sansonetti PJ, Marteyn BS. Shigella diversity and changing landscape: insights for the twenty-first century. Front Cell Infect Microbiol 2016; 6: 45.
[http://dx.doi.org/10.3389/fcimb.2016.00045] [PMID: 27148494]
[19]
Vongsawan AA, Kapatral V, Vaisvil B, et al. The genome of Shigella dysenteriae strain Sd1617 comparison to representative strains in evaluating pathogenesis. FEMS Microbiol Lett 2015; 362(5): fnv011.
[http://dx.doi.org/10.1093/femsle/fnv011] [PMID: 25743074]
[20]
Thompson CN, Duy PT, Baker S. The rising dominance of Shigella sonnei: an intercontinental shift in the etiology of bacillary dysentery. PLoS Negl Trop Dis 2015; 9(6): e0003708.
[http://dx.doi.org/10.1371/journal.pntd.0003708] [PMID: 26068698]
[21]
Vinh H, Nhu NTK, Nga TVT, et al. A changing picture of shigellosis in southern Vietnam: shifting species dominance, antimicrobial susceptibility and clinical presentation. BMC Infect Dis 2009; 9(1): 204.
[http://dx.doi.org/10.1186/1471-2334-9-204] [PMID: 20003464]
[22]
Ud-Din AIMS, Wahid SUH, Latif HA, et al. Changing trends in the prevalence of Shigella species: Emergence of multi-drug resistant Shigella sonnei biotype g in Bangladesh. PLoS One 2013; 8(12): e82601.
[http://dx.doi.org/10.1371/journal.pone.0082601] [PMID: 24367527]
[23]
Ranjbar R, Soltan Dallal MM, Talebi M, Pourshafie MR. Increased isolation and characterization of Shigella sonnei obtained from hospitalized children in Tehran, Iran. J Health Popul Nutr 2008; 26(4): 426-30.
[PMID: 19069621]
[24]
Bangtrakulnonth A, Vieira AR, Lo Fo Wong DMA, et al. Shigella from humans in Thailand during 1993 to 2006: spatial-time trends in species and serotype distribution. Foodborne Pathog Dis 2008; 5(6): 773-84.
[http://dx.doi.org/10.1089/fpd.2008.0109] [PMID: 19086804]
[25]
Gu B, Cao Y, Pan S, et al. Comparison of the prevalence and changing resistance to nalidixic acid and ciprofloxacin of Shigella between Europe–America and Asia–Africa from 1998 to 2009. Int J Antimicrob Agents 2012; 40(1): 9-17.
[http://dx.doi.org/10.1016/j.ijantimicag.2012.02.005] [PMID: 22483324]
[26]
Moradi F, Hadi N, Akbari M, Hashemizadeh Z, Jahromi RR. Frequency and antimicrobial resistance of Shigella species in Iran during 2000-2020. Int J Antimicrob Agents 2021; 13(2)
[27]
Ranjbar R, Behnood V, Memariani H, Najafi A, Moghbeli M, Mammina C. Molecular characterisation of quinolone-resistant Shigella strains isolated in Tehran, Iran. J Glob Antimicrob Resist 2016; 5: 26-30.
[http://dx.doi.org/10.1016/j.jgar.2016.01.010] [PMID: 27436462]
[28]
Abbasi E, Abtahi H, van Belkum A, Ghaznavi-Rad E. Multidrug-resistant Shigella infection in pediatric patients with diarrhea from central Iran. Infect Drug Resist 2019; 12: 1535-44.
[http://dx.doi.org/10.2147/IDR.S203654] [PMID: 31239729]
[29]
Karimi-Yazdi M, Ghalavand Z, Shabani M, et al. High rates of antimicrobial resistance and virulence gene distribution among Shigella spp. isolated from pediatric patients in Tehran, Iran. Infect Drug Resist 2020; 13: 485-92.
[http://dx.doi.org/10.2147/IDR.S238559] [PMID: 32104018]
[30]
Aminshahidi M, Arastehfar A, Pouladfar G, Arman E, Fani F. Diarrheagenic Escherichia coli and Shigella with high rate of extended-spectrum Beta-lactamase production: two predominant etiological agents of acute diarrhea in Shiraz, Iran. Microb Drug Resist 2017; 23(8): 1037-44.
[http://dx.doi.org/10.1089/mdr.2017.0204] [PMID: 29106325]
[31]
Shokoohizadeh L, Kaydani GA, Ekrami A. Molecular characterization of Shigella spp. isolates from a pediatric hospital in Southwestern Iran. Gastroenterol Hepatol Bed Bench 2017; 10(4): 319-22.
[PMID: 29379598]
[32]
Fatahi A, Ajami A, Bozorgzad M, Nekoeian S, Khazeni A. A comparison between culture and multiplex PCR for detection and identification of Shigella species in patients with Shigellosis from Isfahan province in 2014-2015. J Med Microbiol Infect Dis 2015; 3(1): 23-8.
[33]
Mostafavi N, Bighamian M, Mobasherizade S, Kelishadi R. Resistance of Shigella strains to extended-spectrum cephalosporins in Isfahan province. Med J Islam Repub Iran 2016; 30: 428.
[PMID: 28210593]
[34]
Pour MBMG, Shokoohizadeh L, Navab-Akbar FT. Analysis of clonal relationships among Shigella spp. isolated from children with shigellosis in Ahvaz, Iran. Arch Adv Biosci 2016; 7(2): 45-51.
[35]
Talebreza A, Memariani M, Memariani H, Shirazi MH, Eghbali Shamsabad P, Bakhtiari M. Prevalence and antibiotic susceptibility of Shigella species isolated from pediatric patients in Tehran. Arch Pediatr Infect Dis 2015; 4(1)
[http://dx.doi.org/10.5812/pedinfect.32395]
[36]
Nikfar R, Shamsizadeh A, Darbor M, Khaghani S, Moghaddam M. A Study of prevalence of Shigella species and antimicrobial resistance patterns in paediatric medical center, Ahvaz, Iran. Iran J Microbiol 2017; 9(5): 277-83.
[PMID: 29296272]
[37]
Bakhshi B, Afshari N, Fallah F. Enterobacterial repetitive intergenic consensus (ERIC)-PCR analysis as a reliable evidence for suspected Shigella spp. outbreaks. Braz J Microbiol 2018; 49(3): 529-33.
[http://dx.doi.org/10.1016/j.bjm.2017.01.014] [PMID: 29482996]
[38]
Farahani NN, Jazi FM, Nikmanesh B, Asadolahi P, Kalani BS, Amirmozafari N. Prevalence and antibiotic susceptibility patterns of Salmonella and Shigella species isolated from pediatric diarrhea in Tehran. Arch Pediatr Infect Dis 2018; 6(4)
[39]
Soltan Dallal MM, Ranjbar R, Yaghoubi S, Rajabi Z, Aminharati F, Adeli Behrooz H. Molecular epidemiology and genetic characterization of Shigella in pediatric patients in Iran. Infez Med 2018; 26(4): 321-8.
[PMID: 30555135]
[40]
Zamanlou S, Rezaee MA, Aghazadeh M, Ghotaslou R, Nave HH, Khalili Y. Genotypic diversity of multidrug resistant Shigella species from Iran. Infect Chemother 2018; 50(1): 29-37.
[http://dx.doi.org/10.3947/ic.2018.50.1.29] [PMID: 29637750]
[41]
Zamanlou S, Ahangarzadeh Rezaee M, Aghazadeh M, Ghotaslou R, Babaie F, Khalili Y. Characterization of integrons, extended-spectrum β-lactamases, AmpC cephalosporinase, quinolone resistance, and molecular typing of Shigella spp. from Iran. Infect Dis 2018; 50(8): 616-24.
[http://dx.doi.org/10.1080/23744235.2018.1455222] [PMID: 29595080]
[42]
Mamishi S, Arab Yazdi Z, Mahmoudi S, Moradzadeh M, Taghi Haghi Ashtiani M, Pourakbari B. Antimicrobial-resistance pattern of Shigella species in children: A six-year study in an Iranian referral Hospital. Ann Ig 2019; 31(4): 356-64.
[PMID: 31268120]
[43]
Moosavian M, Seyed-Mohammadi S, Sheikh AF, et al. Prevalence of enterotoxin-encoding genes among diverse Shigella strains isolated from patients with diarrhea, southwest Iran. Acta Microbiol Immunol Hung 2018; 66(1): 91-101.
[http://dx.doi.org/10.1556/030.65.2018.037] [PMID: 30203689]
[44]
Sheikh AF, Moosavian M, Abdi M, et al. Prevalence and antimicrobial resistance of Shigella species isolated from diarrheal patients in Ahvaz, southwest Iran. Infect Drug Resist 2019; 12: 249-53.
[45]
Teimourpour R, Babapour B, Esmaelizad M, Arzanlou M, Peeri-Doghaheh H. Molecular characterization of quinolone resistant Shigella spp. isolates from patients in Ardabil, Iran. Iran J Microbiol 2019; 11(6): 496-501.
[PMID: 32148681]
[46]
Soltan Dallal MM, Motalebi S, Masoumi Asl H, Sharifi Yazdi MK, Rahimi Forushani A. Antimicrobial investigation on the multi-state outbreak of salmonellosis and shigellosis in Iran. Med J Islam Repub Iran 2020; 34: 49.
[http://dx.doi.org/10.47176/mjiri.34.49] [PMID: 32884924]
[47]
Farajzadeh Sheikh A, Moradi Bandbal M, Saki M. Emergence of multidrug-resistant Shigella species harboring extended-spectrum beta-lactamase genes in pediatric patients with diarrhea from southwest of Iran. Mol Biol Rep 2020; 47(9): 7097-106.
[http://dx.doi.org/10.1007/s11033-020-05776-x] [PMID: 32894435]
[48]
Salimiyan rizi K, Farsiani H, Sasan MS. High rate of resistance to ceftriaxone and azithromycin among Shigella spp. isolates at three children’s referral hospitals in Northeast Iran. J Infect Chemother 2020; 26(9): 955-8.
[http://dx.doi.org/10.1016/j.jiac.2020.04.022] [PMID: 32446727]
[49]
Jafari-Sales A. Shariat A. Antibiotic resistance pattern in Shigella species isolated from children with acute diarrhea in Tabriz city, Iran. J Health Sci Medicine 2021; 4(2): 219-22.
[http://dx.doi.org/10.32322/jhsm.859497]
[50]
Jomehzadeh N, Afzali M, Ahmadi K, Salmanzadeh S, Mehr FJ. Antimicrobial resistance patterns and prevalence of integrons in Shigella species isolated from children with diarrhea in southwest Iran. APJTM 2021; 14(2): 78.
[51]
Moghaddami M, Davoodabadi A, Mehrabani S. Antibiotic resistance of Shigella and Salmonella bacteria in children with acute diarrhea. J Mazandaran Univ Med Sci 2021; 31(198): 60-72.
[52]
Mohebi S, Nave HH, Javadi K, et al. Evaluate the distribution of virulence genes and to investigate antibiotic resistance pattern among Shigella species isolated from children with shigellosis in Iran. Gene Rep 2021; 23: 101189.
[http://dx.doi.org/10.1016/j.genrep.2021.101189]
[53]
Pakbin B, Didban A, Monfared YK, Mahmoudi R, Peymani A, Modabber MR. Antibiotic susceptibility and genetic relatedness of Shigella species isolated from food and human stool samples in Qazvin, Iran. BMC Res Notes 2021; 14(1): 144.
[http://dx.doi.org/10.1186/s13104-021-05554-3] [PMID: 33865447]
[54]
Behruznia P, Sadredinamin M, Hashemi A, et al. Decreased susceptibility of Shigella isolates to azithromycin in children in Tehran, Iran. Can J Infect Dis Med Microbiol 2022; 2022: 4503964.
[http://dx.doi.org/10.1155/2022/4503964]
[55]
Mamishi S, Pourakbari B, Ghaffari CM, Mahmoudi S, Abdolsalehi MR, Hosseinpour SR. High frequency of antimicrobial resistance and virulence gene in Shigella species isolated from pediatric patients in an Iranian Referral Hospital. Acta Biomed 2022; 93(2): e2022027.
[PMID: 35546037]
[56]
Sabour S, Teimourpour A, Mohammadshahi J, et al. Molecular detection and characterization of Shigella spp. harboring extended-spectrum β-lactamase genes in children with diarrhea in northwest Iran. Mol Cell Pediatr 2022; 9(1): 19.
[http://dx.doi.org/10.1186/s40348-022-00152-0] [PMID: 36480097]
[57]
Zamanlou S, Omidnia P, Babaie F, et al. Emergence of azithromycin and third-generation cephalosporins resistant Shigella isolated from Iranian children. Gene Rep 2022; 26: 101485.
[http://dx.doi.org/10.1016/j.genrep.2021.101485]
[58]
Bacterial Infections of Humans. Springer NY 2009.
[59]
McNeil CJ, Kirkcaldy RD, Workowski K. Enteric Infections in Men Who Have Sex With Men. Clin Infect Dis 2022; 74(S2): S169-78.
[http://dx.doi.org/10.1093/cid/ciac061] [PMID: 35416972]
[60]
Zhao L, Xiong Y, Meng D, et al. An 11-year study of shigellosis and Shigella species in Taiyuan, China: Active surveillance, epidemic characteristics, and molecular serotyping. J Infect Public Health 2017; 10(6): 794-8.
[http://dx.doi.org/10.1016/j.jiph.2017.01.009] [PMID: 28188118]
[61]
Halimeh FB, Rafei R, Osman M, et al. Historical, current, and emerging tools for identification and serotyping of Shigella. Braz J Microbiol 2021; 52(4): 2043-55.
[http://dx.doi.org/10.1007/s42770-021-00573-5] [PMID: 34524650]
[62]
Du T. Lin Jh, Zhao Jh, Wang Hb, Mo Qh. Development and evaluation of an iiPCR assay for salmonella and Shigella detection on a field-deployable PCR system. Can J Infect Dis Med Microbiol 2020; 2020: 9373984.
[http://dx.doi.org/10.1155/2020/9373984]
[63]
Yan C, Chen Y, Miao Z, Qin S, Gu H, Cai J. Spatiotemporal characteristics of bacillary dysentery from 2005 to 2017 in Zhejiang Province, China. Int J Environ Res Public Health 2018; 15(9): 1826.
[http://dx.doi.org/10.3390/ijerph15091826] [PMID: 30149494]
[64]
Torabi Z, Nematollahi S, Ahmadnezhad E, Holakoie Naieni K. An epidemic of Shigella flexneri and its related factors in Isfahan in Spring 2015: A case–control study. Majallah-i Ipidimiyuluzhi-i Iran 2018; 14(2): 177-86.
[65]
Lampel KA, Formal SB, Maurelli AT. A brief history of Shigella. Ecosal Plus 2018; 8(1) ecosalplus.ESP-0006-2017. http://dx.doi.org/10.1128/ecosalplus.ESP-0006-2017 PMID: 29318984
[66]
Brotcke Zumsteg A, Goosmann C, Brinkmann V, Morona R, Zychlinsky A. IcsA is a Shigella flexneri adhesin regulated by the type III secretion system and required for pathogenesis. Cell Host Microbe 2014; 15(4): 435-45.
[http://dx.doi.org/10.1016/j.chom.2014.03.001] [PMID: 24721572]
[67]
Schroeder GN, Jann NJ, Hilbi H. Intracellular type III secretion by cytoplasmic Shigella flexneri promotes caspase-1-dependent macrophage cell death. Microbiology 2007; 153(9): 2862-76.
[http://dx.doi.org/10.1099/mic.0.2007/007427-0] [PMID: 17768231]
[68]
Schroeder GN, Hilbi H. Molecular pathogenesis of Shigella spp.: Controlling host cell signaling, invasion, and death by type III secretion. Clin Microbiol Rev 2008; 21(1): 134-56.
[http://dx.doi.org/10.1128/CMR.00032-07] [PMID: 18202440]
[69]
Yang SC, Hung CF, Aljuffali IA, Fang JY. The roles of the virulence factor IpaB in Shigella spp. in the escape from immune cells and invasion of epithelial cells. Microbiol Res 2015; 181: 43-51.
[http://dx.doi.org/10.1016/j.micres.2015.08.006] [PMID: 26640051]
[70]
Khan WA, Griffiths JK, Bennish ML. Gastrointestinal and extra-intestinal manifestations of childhood shigellosis in a region where all four species of Shigella are endemic. PLoS One 2013; 8(5): e64097.
[http://dx.doi.org/10.1371/journal.pone.0064097] [PMID: 23691156]
[71]
Akhondi H, Simonsen KA. Bacterial Diarrhea. StatPearls Publishing Treasure Island, FL 2019.
[72]
Miron D, Sochotnick I, Yardeni D, Kawar B, Siplovich L. Surgical complications of shigellosis in children. Pediatr Infect Dis J 2000; 19(9): 898-900.
[http://dx.doi.org/10.1097/00006454-200009000-00022] [PMID: 11001121]
[73]
Pazhani GP, Ramamurthy T, Mitra U, Bhattacharya SK, Niyogi SK. Species diversity and antimicrobial resistance of Shigella spp. isolated between 2001 and 2004 from hospitalized children with diarrhoea in Kolkata (Calcutta), India. Epidemiol Infect 2005; 133(6): 1089-95.
[http://dx.doi.org/10.1017/S0950268805004498] [PMID: 16274506]
[74]
Binet R, Lampel KA. Shigella species. Fundam Front. J Microbiol 2012; 377-99.
[75]
Pourakbari B, Mamishi S, Kohan L, et al. Lethal toxic encephalopathy due to childhood shigellosis or Ekiri syndrome. J Microbiol Immunol Infect 2012; 45(2): 147-50.
[http://dx.doi.org/10.1016/j.jmii.2011.09.005] [PMID: 22177366]
[76]
Chompook P, Todd J, Wheeler JG, von Seidlein L, Clemens J, Chaicumpa W. Risk factors for shigellosis in Thailand. Int J Infect Dis 2006; 10(6): 425-33.
[http://dx.doi.org/10.1016/j.ijid.2006.05.011] [PMID: 16997593]
[77]
Al-Dahmoshi HO, Al-Khafaji NS, Al-Allak MH, Salman WK, Alabbasi AH. A review on shigellosis: Pathogenesis and antibiotic Resistance. Drug Invent Today 2020; 14(5): 793-8.
[78]
Kotloff KL. Shigella infection in children and adults: A formidable foe. Lancet Glob Health 2017; 5(12): e1166-7.
[http://dx.doi.org/10.1016/S2214-109X(17)30431-X] [PMID: 29132604]
[79]
Troeger C, Forouzanfar M, Rao PC, et al. Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: A systematic analysis for the Global Burden of Disease Study 2015. Lancet Infect Dis 2017; 17(9): 909-48.
[http://dx.doi.org/10.1016/S1473-3099(17)30276-1] [PMID: 28579426]
[80]
Tau NP, Smith AM, Sooka A, Keddy KH, Africa MDSIS. Molecular characterization of extended-spectrum β-lactamase-producing Shigella isolates from humans in South Africa, 2003–2009. J Med Microbiol 2012; 61(1): 162-4.
[http://dx.doi.org/10.1099/jmm.0.033142-0] [PMID: 21903820]
[81]
Murphy TV, Nelson JD. Shigella vaginitis: Report of 38 patients and review of the literature. Pediatrics 1979; 63(4): 511-6.
[http://dx.doi.org/10.1542/peds.63.4.511] [PMID: 375177]
[82]
Simon DG, Kaslow RA, Rosenbaum J, Kaye RL, Calin A. Reiter’s syndrome following epidemic shigellosis. J Rheumatol 1981; 8(6): 969-73.
[PMID: 6948959]
[83]
Mark Taylor C. Enterohaemorrhagic Escherichia coli and Shigella dysenteriae type 1-induced haemolytic uraemic syndrome. Pediatr Nephrol 2008; 23(9): 1425-31.
[http://dx.doi.org/10.1007/s00467-008-0820-3] [PMID: 18493800]
[84]
Kotloff KL, Riddle MS, Platts-Mills JA, Pavlinac P, Zaidi AKM. Shigellosis. Lancet 2018; 391(10122): 801-12.
[http://dx.doi.org/10.1016/S0140-6736(17)33296-8] [PMID: 29254859]
[85]
Dutta P, Mitra U, Dutta S, et al. Hypo‐osmolar oral rehydration salts solution in dehydrating persistent diarrhoea in children: Double‐blind, randomized, controlled clinical trial. Acta Paediatr 2000; 89(4): 411-6.
[http://dx.doi.org/10.1111/j.1651-2227.2000.tb00078.x] [PMID: 10830451]
[86]
Zhu Y, Li H, Hu L, et al. Structure of a Shigella effector reveals a new class of ubiquitin ligases. Nat Struct Mol Biol 2008; 15(12): 1302-8.
[http://dx.doi.org/10.1038/nsmb.1517] [PMID: 18997779]
[87]
Murphy GS, Bodhidatta L, Echeverria P, et al. Ciprofloxacin and loperamide in the treatment of bacillary dysentery. Ann Intern Med 1993; 118(8): 582-6.
[http://dx.doi.org/10.7326/0003-4819-118-8-199304150-00002] [PMID: 8452323]
[88]
MurphyERRoßmanith J, Sieg J, et al. Regulation of OmpA translation and Shigella dysenteriae virulence by an RNA thermometer. Infect Immun 2020; 88(3): e00871-19.
[http://dx.doi.org/10.1128/IAI.00871-19] [PMID: 31792074]
[89]
Erdman SM, Buckner EE, Hindler JF. Options for treating resistant Shigella species infections in children. J Pediatr Pharmacol Ther 2008; 13(1): 29-43.
[http://dx.doi.org/10.5863/1551-6776-13.1.29] [PMID: 23055862]
[90]
Qiu S, Liu K, Yang C, et al. A Shigella sonnei clone with extensive drug resistance associated with waterborne outbreaks in China. Nat Commun 2022; 13(1): 7365.
[http://dx.doi.org/10.1038/s41467-022-35136-1] [PMID: 36450777]
[91]
Toro CS, Salazar JC, Montero DA, et al. Antimicrobial resistance dynamics in chilean Shigella sonnei strains within two decades: Role of Shigella resistance locus pathogenicity island and class 1 and class 2 integrons. Front Microbiol 2022; 12: 794470.
[http://dx.doi.org/10.3389/fmicb.2021.794470] [PMID: 35185820]
[92]
Avakh Majalan P, Hajizade A, Nazarian S, Pourmand MR, Siyavoshani KA. Investigating the prevalence of Shigella species and their antibiotic resistance pattern in children with acute diarrhea referred to selected hospitals in Tehran, Iran. J Appl Biotechnol Rep 2018; 5(1): 70-4.
[http://dx.doi.org/10.29252/JABR.05.02.06]
[93]
Edwards BH. Salmonella and Shigella species. Clin Lab Med 1999; 19(3): 469-87.
[http://dx.doi.org/10.1016/S0272-2712(18)30099-4] [PMID: 10549421]
[94]
Chisti MJ, Faruque ASG, Khan WA, Das SK, Zabed MB, Salam MA. Characteristics of children with Shigella encephalopathy: Experience from a large urban diarrhea treatment center in Bangladesh. Pediatr Infect Dis J 2010; 29(5): 444-7.
[http://dx.doi.org/10.1097/INF.0b013e3181cb4608] [PMID: 20016394]
[95]
Aeschlimann JR. The role of multidrug efflux pumps in the antibiotic resistance of Pseudomonas aeruginosa and other gram-negative bacteria. Pharmacotherapy 2003; 23(7): 916-24.
[http://dx.doi.org/10.1592/phco.23.7.916.32722] [PMID: 12885104]
[96]
Gaurav A, Singh S, Gill JPS, Kumar R, Kumar D. Isolation and identification of Shigella spp from human fecal samples collected from Pantnagar, India. Vet World 2013; 6(7): 376.
[http://dx.doi.org/10.5455/vetworld.2013.376-379]
[97]
Srinivasa H, Baijayanti M, Raksha Y. Magnitude of drug resistant Shigellosis: A report from Bangalore. Indian J Med Microbiol 2009; 27(4): 358-60.
[http://dx.doi.org/10.4103/0255-0857.55460] [PMID: 19736408]
[98]
Nataro JP, Seriwatana J, Fasano A, et al. Identification and cloning of a novel plasmid-encoded enterotoxin of enteroinvasive Escherichia coli and Shigella strains. Infect Immun 1995; 63(12): 4721-8.
[http://dx.doi.org/10.1128/iai.63.12.4721-4728.1995] [PMID: 7591128]
[99]
Noriega FR, Liao FM, Maneval DR, Ren S, Formal SB, Levine MM. Strategy for cross-protection among Shigella flexneri serotypes. Infect Immun 1999; 67(2): 782-8.
[http://dx.doi.org/10.1128/IAI.67.2.782-788.1999] [PMID: 9916090]
[100]
Levine MM, Kotloff KL, Barry EM, Pasetti MF, Sztein MB. Clinical trials of Shigella vaccines: Two steps forward and one step back on a long, hard road. Nat Rev Microbiol 2007; 5(7): 540-53.
[http://dx.doi.org/10.1038/nrmicro1662] [PMID: 17558427]
[101]
Chompook P, Samosornsuk S, von Seidlein L, et al. Estimating the burden of shigellosis in Thailand: 36-month population-based surveillance study. Bull World Health Organ 2005; 83(10): 739-46.
[PMID: 16283050]
[102]
Taneja N, Mewara A. Shigellosis: Epidemiology in India. Indian J Med Res 2016; 143(5): 565-76.
[http://dx.doi.org/10.4103/0971-5916.187104] [PMID: 27487999]
[103]
von Seidlein L, Kim DR, Ali M, et al. A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology. PLoS Med 2006; 3(9): e353.
[http://dx.doi.org/10.1371/journal.pmed.0030353] [PMID: 16968124]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy